Larry Robbins's ABBV Position Overview
Larry Robbins (via Glenview Capital Management, LLC) currently holds 148,913 shares of AbbVie Inc. (ABBV) worth $37.47 M, representing 0.68% of the portfolio. First purchased in 2015-Q1, this medium-term investment has been held for 14 quarters.
Based on 13F filings, Larry Robbins has maintained a strategic position in ABBV, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2015, adding 15.41 M shares. Largest reduction occurred in Q3 2016, reducing 6.42 M shares.
Analysis based on 13F filings available since 2013 Q2
Larry Robbins's AbbVie (ABBV) Holding Value Over Time
Track share changes against reported price movement
Quarterly AbbVie (ABBV) Trades by Larry Robbins
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +148,913 | New Buy | 148,913 | $251.64 |
| Q1 2018 | -1.36 M | Sold Out | 0 | $0.00 |
| Q4 2017 | -3.98 M | Reduce 74.45% | 1.36 M | $96.71 |
| Q3 2017 | -768,838 | Reduce 12.58% | 5.34 M | $88.86 |
| Q2 2017 | -1.19 M | Reduce 16.32% | 6.11 M | $72.51 |
| Q1 2017 | -1.82 M | Reduce 19.91% | 7.3 M | $65.16 |
| Q4 2016 | +3.09 M | Add 51.19% | 9.12 M | $62.62 |
| Q3 2016 | -6.42 M | Reduce 51.58% | 6.03 M | $63.07 |
| Q2 2016 | -1.23 M | Reduce 9.00% | 12.45 M | $61.91 |
| Q1 2016 | +141,773 | Add 1.05% | 13.69 M | $57.12 |
| Q4 2015 | -2.63 M | Reduce 16.24% | 13.54 M | $59.24 |
| Q3 2015 | -1.69 M | Reduce 9.44% | 16.17 M | $54.41 |
| Q2 2015 | +15.41 M | Add 630.71% | 17.86 M | $67.19 |
| Q1 2015 | +2.44 M | New Buy | 2.44 M | $58.54 |
Larry Robbins's AbbVie Investment FAQs
Larry Robbins first purchased AbbVie Inc. (ABBV) in Q1 2015, acquiring 2,443,632 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Larry Robbins has held AbbVie Inc. (ABBV) for 14 quarters since Q1 2015.
Larry Robbins's largest addition to AbbVie Inc. (ABBV) was in Q2 2015, adding 17,855,941 shares worth $1.2 B.
According to the latest 13F filing for Q2 2026, Larry Robbins's firm, Glenview Capital Management, LLC, owns 148,913 shares of AbbVie Inc. (ABBV), valued at approximately $37.47 M.
As of the Q2 2026 filing, AbbVie Inc. (ABBV) represents approximately 0.68% of Larry Robbins's publicly disclosed stock portfolio, making it one of their key holdings.
Larry Robbins's peak holding in AbbVie Inc. (ABBV) was 17,855,941 shares, as reported at the end of Q2 2015.